These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9679768

  • 1. Estramustine resistance correlates with tau over-expression in human prostatic carcinoma cells.
    Sangrajrang S, Denoulet P, Millot G, Tatoud R, Podgorniak MP, Tew KD, Calvo F, Fellous A.
    Int J Cancer; 1998 Aug 12; 77(4):626-31. PubMed ID: 9679768
    [Abstract] [Full Text] [Related]

  • 2. Association of estramustine resistance in human prostatic carcinoma cells with modified patterns of tubulin expression.
    Sangrajrang S, Denoulet P, Laing NM, Tatoud R, Millot G, Calvo F, Tew KD, Fellous A.
    Biochem Pharmacol; 1998 Feb 01; 55(3):325-31. PubMed ID: 9484799
    [Abstract] [Full Text] [Related]

  • 3. Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance.
    Ranganathan S, Dexter DW, Benetatos CA, Chapman AE, Tew KD, Hudes GR.
    Cancer Res; 1996 Jun 01; 56(11):2584-9. PubMed ID: 8653701
    [Abstract] [Full Text] [Related]

  • 4. Estramustine resistance.
    Sangrajrang S, Calvo F, Fellous A.
    Gen Pharmacol; 1999 Aug 01; 33(2):107-13. PubMed ID: 10461848
    [Abstract] [Full Text] [Related]

  • 5. Different microtubule network alterations induced by pachymatismin, a new marine glycoprotein, on two prostatic cell lines.
    Sangrajrang S, Zidane M, Berda P, Moré MT, Calvo F, Fellous A.
    Cancer Chemother Pharmacol; 2000 Aug 01; 45(2):120-6. PubMed ID: 10663626
    [Abstract] [Full Text] [Related]

  • 6. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
    Ranganathan S, McCauley RA, Dexter DW, Hudes GR.
    Br J Cancer; 2001 Sep 01; 85(5):735-40. PubMed ID: 11531260
    [Abstract] [Full Text] [Related]

  • 7. Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents.
    Ranganathan S, Dexter DW, Benetatos CA, Hudes GR.
    Biochim Biophys Acta; 1998 Jan 21; 1395(2):237-45. PubMed ID: 9473684
    [Abstract] [Full Text] [Related]

  • 8. P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine.
    Speicher LA, Barone LR, Chapman AE, Hudes GR, Laing N, Smith CD, Tew KD.
    J Natl Cancer Inst; 1994 May 04; 86(9):688-94. PubMed ID: 7908988
    [Abstract] [Full Text] [Related]

  • 9. Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.
    Speicher LA, Laing N, Barone LR, Robbins JD, Seamon KB, Tew KD.
    Mol Pharmacol; 1994 Nov 04; 46(5):866-72. PubMed ID: 7969073
    [Abstract] [Full Text] [Related]

  • 10. Effects of microtubule inhibitors-taxol, vinblastine and estramustine on the growth and p53 gene expression in the hormone independent human prostatic JCA-1 cells.
    Darby E, An S, Ng C, Hsieh TC, Mallouh C, Wu JM.
    Anticancer Res; 1996 Nov 04; 16(6B):3647-52. PubMed ID: 9042236
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of lipophilins as determinants of tumor cell response to estramustine.
    Tucker JM, Lipatova Z, Beljanski V, Townsend DM, Tew KD.
    J Pharmacol Exp Ther; 2005 Dec 04; 315(3):1158-62. PubMed ID: 16120813
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines.
    Speicher LA, Barone L, Tew KD.
    Cancer Res; 1992 Aug 15; 52(16):4433-40. PubMed ID: 1353706
    [Abstract] [Full Text] [Related]

  • 15. Growth inhibiting effect of estramustine on two prostatic carcinoma cell lines, LNCaP and LNCaP-r.
    Hansenson M, Lundh B, Hartley-Asp B, Pousette A.
    Urol Res; 1988 Aug 15; 16(5):357-61. PubMed ID: 3201650
    [Abstract] [Full Text] [Related]

  • 16. Estramustine: a novel radiation enhancer in human carcinoma cells.
    Ryu S, Gabel M, Khil MS, Lee YJ, Kim SH, Kim JH.
    Int J Radiat Oncol Biol Phys; 1994 Aug 30; 30(1):99-104. PubMed ID: 7916009
    [Abstract] [Full Text] [Related]

  • 17. Growth of prostatic cancer cells, DU 145, as multicellular spheroids and effects of estramustine.
    Essand M, Nilsson S, Carlsson J.
    Anticancer Res; 1993 Aug 30; 13(5A):1261-8. PubMed ID: 8239495
    [Abstract] [Full Text] [Related]

  • 18. Induction of apoptosis by estramustine phosphate mediated by phosphorylation of bcl-2.
    Yoshida D, Noha M, Watanabe K, Takahashi H, Sugisaki Y, Teramoto A.
    J Neurooncol; 2001 Aug 30; 54(1):23-9. PubMed ID: 11763419
    [Abstract] [Full Text] [Related]

  • 19. Interaction of estramustine with tubulin isotypes.
    Laing N, Dahllöf B, Hartley-Asp B, Ranganathan S, Tew KD.
    Biochemistry; 1997 Jan 28; 36(4):871-8. PubMed ID: 9020786
    [Abstract] [Full Text] [Related]

  • 20. Radiation sensitization by estramustine studies on cultured human prostatic cancer cells.
    Eklöv S, Essand M, Carlsson J, Nilsson S.
    Prostate; 1992 Jan 28; 21(4):287-95. PubMed ID: 1461806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.